Navigation Links
Billy Graham Returns Home Following Hospital Observation
Date:10/11/2008

Doctor Confirms Fall Should Not Pose Setback and Expects the 89-Year-Old

Evangelist to Recover Fully

ASHEVILLE, N.C., Oct. 11 /PRNewswire/ -- Evangelist Billy Graham has returned to his mountain home in Montreat, N.C. upon his release this afternoon from Mission Hospital in nearby Asheville following a brief stay. He was admitted for observation after he tripped over one of his three dogs and fell late Friday.

Mr. Graham's physicians said that he suffered no broken bones in the fall. They had offered him the choice of being released or remaining in the hospital overnight for additional observation. He chose to stay rather than make the trip back home, due to the lateness of the hour. His nurses said that Mr. Graham had an uneventful night, was able to sleep and has since been sitting up in a chair and taking full meals.

Mr. Graham's personal physician, Lucian Rice, MD, confirmed the fall should not pose a setback for the 89-year-old evangelist.

"Of course we worry any time a patient takes a fall, especially an older patient," Dr. Rice said. "But while Mr. Graham is somewhat bruised, with some extremely sore muscles, he seems to have suffered no serious injuries, and in fact he was able to work on his physical therapy regimen first thing the next morning. I am encouraging him to remain as active as possible, but to be mindful of his dog, who likes to keep faithfully at his feet. I expect Mr. Graham to recover fully."
Mr. Graham will celebrate his 90th birthday on Nov. 7.

For more information contact:

Merrell Gregory, Mission Hospital

828.213-4806 Office

828.207-2470 Pager

828.778-9040 Cell

merrell.gregory@msj.org

A. Larry Ross,

Director Media/Public Relations for Billy Graham

972.267-1111 Office

469.774-6362 Cell (wknd)

alr@alarryross.com


'/>"/>
SOURCE Mission Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Billy Graham Home After Hospitalization:
2. Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy
3. Healthcare Executive Richard Peitzmeier Returns to Phoenix as Regional Sales Director of SCAN Health Plan Arizona
4. Local Returns as Doctor to Serve Communities of High Desert/Victor Valley & Apple Valley
5. Radiation May Help When Prostate Cancer Returns
6. Michel Nakache Returns to Euro RSCG Life as Worldwide Managing Partner
7. EDS Returns to Georgia With $391 Million Medicaid Win
8. USA TODAY Weight-Loss Challenge Returns For 5th Year With Eight Weeks of Compelling Stories and Online Features
9. Fred Hutchinson Cancer Research Centers Big Expedition for Cancer Research Team Returns From Reconnaissance Flight Over Alaskas Glacier Bay Park
10. ORBIS Internationals Flying Eye Hospital Returns to Myanmar
11. Study Shows New Therapy Opens Blocked Fallopian Tubes, Returns Fertility Without Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:American Laser Centers Names Bill Van Huis as Chief Revenue Officer 2Health News:AT&T to Deliver Country's First Statewide eHealth Exchange Zone 2Health News:AT&T to Deliver Country's First Statewide eHealth Exchange Zone 3Health News:AT&T to Deliver Country's First Statewide eHealth Exchange Zone 4Health News:AT&T to Deliver Country's First Statewide eHealth Exchange Zone 5Health News:Acuo Technologies(R) Announces Record Sales and Implementation Growth 2Health News:Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 2Health News:Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 3Health News:Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 4Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 2Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 3Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 4Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 5Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 6Health News:Harris Corporation Unveils Broadcast-Style Multiviewers for Real-Time Multi- Screen Access to Medical Information 2Health News:Harris Corporation Unveils Broadcast-Style Multiviewers for Real-Time Multi- Screen Access to Medical Information 3
Breaking Medicine Technology:Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 2Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 3Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 4Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 5Nplate(R) Data From MDS Studies Presented at ASH 2Nplate(R) Data From MDS Studies Presented at ASH 3Nplate(R) Data From MDS Studies Presented at ASH 4Nplate(R) Data From MDS Studies Presented at ASH 5Nplate(R) Data From MDS Studies Presented at ASH 6Nplate(R) Data From MDS Studies Presented at ASH 7Nplate(R) Data From MDS Studies Presented at ASH 8Nplate(R) Data From MDS Studies Presented at ASH 9Nplate(R) Data From MDS Studies Presented at ASH 10Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2New and Updated Online Tutorials for ArrayExpress Allen Brain Atlas and CleanEx from OpenHelix 54389 1New and Updated Online Tutorials for ArrayExpress Allen Brain Atlas and CleanEx from OpenHelix 54389 2New and Updated Online Tutorials for ArrayExpress Allen Brain Atlas and CleanEx from OpenHelix 54389 3Cancer Mortality Rates Experience Steady Decline 54386 1Cancer Mortality Rates Experience Steady Decline 54386 2Cancer Mortality Rates Experience Steady Decline 54386 3Cancer Mortality Rates Experience Steady Decline 54386 4APHL Chosen by PEPFAR to Develop Global Health Laboratory Systems 54384 1APHL Chosen by PEPFAR to Develop Global Health Laboratory Systems 54384 2